The $3.4 Billion Lesson Pharma Faces in Shelved Drugs
Thousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
Sudden budget increases can catch you off guard. Build buffers and flexible limits to adjust calmly and maintain financial balance.
15,135 articlesThousands of shelved drug candidates could unlock therapies for rare diseases, but funding and partnerships lag. The ...
The UK gilt market is spiraling, with the 10-year yield climbing to a 17-year high, signaling renewed stress for pens...
Oracle has fallen this year as investors weigh legacy strengths against AI disruption. This guide breaks down the AI ...
Copper demand is surging as data centers, EVs, and renewables push miners to expand. BHP reorganizes around copper, w...
A new wave in AI infrastructure is building: the million-XPU data center. This article explains what it is, why it ma...
Are you leaning toward megacap growth or small-cap opportunities? This guide breaks down MGK vs IWM, reveals how to b...
XRP is navigating a critical moment as Ripple deploys AI-driven security testing across the XRP Ledger. The move aims...
A geopolitical chokepoint isn't just about oil. The Strait of Hormuz also moves a vital portion of global fertilizer....
A major reshuffle around Microsoft and OpenAI could shift AI momentum in tech clouds. This article explains why amazo...
A new NRMLA webinar explores how caregiving and intergenerational concerns influence reverse mortgage choices, offeri...
Districts have spent tens of millions to ban phones in classrooms, but a sweeping study finds little to no improvemen...
Alphabet is tightening the gap with Nvidia as AI wins bolster its diversified business empire. Investors weigh the im...